Skip to main content
Clinical Trials/ISRCTN16242918
ISRCTN16242918
Active, not recruiting
未知

A longitudinal pilot study to investigate the use of GPS trackers in dementia patients who are at risk of wandering

South West Yorkshire Partnership NHS Foundation Trust0 sites45 target enrollmentMay 9, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Quality of life of people diagnosed with dementia or memory impairment who are at risk of wandering or getting lost
Sponsor
South West Yorkshire Partnership NHS Foundation Trust
Enrollment
45
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 9, 2022
End Date
January 31, 2023
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Individuals must have a designated family member/close friend who will supervise the use of the device including being able to access and use the accompanying software.
  • 2\. Nominated friend must not be any member of paid care staff
  • 3\. Participants must live in an area served by South West Yorkshire Partnership NHS Trust memory services
  • 4\. Individuals must be either living in their own homes or in supported accommodation

Exclusion Criteria

  • 1\. If an individual does not have a close family member identified at the outset, he/she will be excluded from the study
  • 2\. If participants move out of this area to a different locality before the end of six months duration of the study, they will cease to be part of the study
  • 3\. If individuals make a permanent move to a 24\-hour residential care setting, they will cease to be part of the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
A prospective cohort study to investigate the use of alfa V beta 3 integrin scintigraphic imaging with 99mTC-NC100692 to predict scar formation and heart failure after myocardial infarction in patients. - ANG692
EUCTR2009-010608-27-NLMUMC+
Withdrawn
Phase 2
A prospective cohort study to investigate the use of avβ3-integrin scintigraphic imaging with 99mTc-NC100692 injection as a surrogate endpoint for therapeutic interventions in patients with myocardial infarction.heart failuremyocardial infarction10019280
NL-OMON35493Medisch Universitair Ziekenhuis Maastricht82
Completed
Not Applicable
An observational longitudinal pilot study to assess pharyngeal carriage of Neisseria meningitidis in South Australian university students.Invasive Meningococcal diseaseNeisseria meningitides pharyngeal carriage
ACTRN12617000233325The University of Adelaide500
Completed
Not Applicable
Prospective, controlled pilot study for the use of non-contact perfusion and thermography measurements in patients with peripheral arterial disease, chronic venous insufficiency, or diabetes mellitus (with or without ulceration) compared to patients with spider vein varikosisCirculatory disorders in venous disease, arterial occlusive disease and diabetes mellitus in cf. to spider veins varicosisI87I70.2E13I83.9Other disorders of veinsAtherosclerosis of arteries of extremitiesOther specified diabetes mellitusVaricose veins of lower extremities without ulcer or inflammation
DRKS00013886Phlebologisches Studienzentrum am Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken37
Active, not recruiting
Phase 1
prolonged-release oral fampridine in Neuromyelitis Optica (NMO), Pilot feasibility Studyeuromyelitis optica (NMO)Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2013-000529-30-GBWalton Centre Foundation Trust20